+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Brain Barrier Drug Delivery"

Global Drug Delivery Across Blood Brain Barrier Market by Drug Delivery Technology (Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB), Application (Alzheimer's Disease, Brain Cancer, Epilepsy) - Forecast 2024-2030 - Product Thumbnail Image

Global Drug Delivery Across Blood Brain Barrier Market by Drug Delivery Technology (Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB), Application (Alzheimer's Disease, Brain Cancer, Epilepsy) - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Global Drug Delivery Devices Market Size, Share & Trends Analysis Report by Application (Oncology, Infectious Diseases), Route Of Administration (Oral, Transdermal, Injectable), End-use, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Drug Delivery Devices Market Size, Share & Trends Analysis Report by Application (Oncology, Infectious Diseases), Route Of Administration (Oral, Transdermal, Injectable), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • November 2023
  • 140 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Blood Brain Barrier Drug Delivery market is a subset of the larger Drug Delivery market. It focuses on the development of drugs that can cross the blood-brain barrier, a protective layer of cells that separates the brain from the rest of the body. These drugs are used to treat neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. The Blood Brain Barrier Drug Delivery market is highly competitive, with companies investing heavily in research and development to create new drugs and delivery systems. The market is driven by the increasing prevalence of neurological diseases, as well as the need for more effective treatments. Additionally, advances in technology have enabled the development of more efficient drug delivery systems. Some companies in the Blood Brain Barrier Drug Delivery market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more